Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H25N3O5S |
InChIKeyKPMUSOQFDJSLDU-UHFFFAOYSA-N |
CAS Registry2760511-91-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | CN | 19 Jan 2022 |